| dc.contributor.author |
Gallwitz, Baptist |
|
| dc.date.accessioned |
2017-03-15T14:54:07Z |
|
| dc.date.available |
2017-03-15T14:54:07Z |
|
| dc.date.issued |
2016 |
|
| dc.identifier.issn |
1752-2978 |
|
| dc.identifier.uri |
http://hdl.handle.net/10900/75076 |
|
| dc.language.iso |
en |
en |
| dc.publisher |
Lippincott Williams & Wilkins |
de_DE |
| dc.relation.uri |
http://dx.doi.org/10.1097/MED.0000000000000217 |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.subject.ddc |
610 |
de_DE |
| dc.title |
Glucagon-like peptide-1 and gastric inhibitory polypeptide: new advances |
de_DE |
| dc.type |
Article |
de_DE |
| utue.quellen.id |
20160915142648_01836 |
|
| utue.publikation.seiten |
23-27 |
de_DE |
| utue.personen.roh |
Gallwitz, Baptist |
|
| dcterms.isPartOf.ZSTitelID |
Current Opinion in Endocrinology Diabetes and Obesity |
de_DE |
| dcterms.isPartOf.ZS-Issue |
1 |
de_DE |
| dcterms.isPartOf.ZS-Volume |
23 |
de_DE |
| utue.fakultaet |
04 Medizinische Fakultät |
|